This innovative bone allograft technology employs advanced cold-sterilization and freeze-drying techniques, ensuring microorganism elimination while preserving natural bone properties. It retains essential bone-stimulating agents like BMP-2 and boasts a hydrophilic surface for superior cell and tissue adhesion. Through a unique coating process, it delays initial degradation, providing robust scaffolding for optimal bone regeneration. Its applications span dental implant treatments, contour maintenance, and enhancing human bone allografts by extending the crucial early healing phase.
Bone grafting is the major adjunctive procedure of dental implant treatment. At least 50% of bone graft materials used in dental implant treatment is human bone allograft. Allogenic bone can carry bioactive molecules per se. Drug or bioactive molecules was valued at USD 1.97 Billion in 2021 and is projected to reach USD 5.56 Billion by 2030, growing at a CAGR of 12.49% from 2023 to 2030.